GILEAD SCIENCES INC (GILD) Fundamental Analysis & Valuation

NASDAQ:GILD • US3755581036

Current stock price

127.75 USD
-2.65 (-2.03%)
At close:
127.852 USD
+0.1 (+0.08%)
After Hours:

This GILD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. GILD Profitability Analysis

1.1 Basic Checks

  • GILD had positive earnings in the past year.
  • In the past year GILD had a positive cash flow from operations.
  • In the past 5 years GILD has always been profitable.
  • In the past 5 years GILD always reported a positive cash flow from operatings.
GILD Yearly Net Income VS EBIT VS OCF VS FCFGILD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

1.2 Ratios

  • GILD has a Return On Assets of 14.42%. This is amongst the best in the industry. GILD outperforms 94.76% of its industry peers.
  • With an excellent Return On Equity value of 37.49%, GILD belongs to the best of the industry, outperforming 97.67% of the companies in the same industry.
  • GILD has a better Return On Invested Capital (19.49%) than 97.28% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GILD is significantly below the industry average of 28.06%.
  • The 3 year average ROIC (17.55%) for GILD is below the current ROIC(19.49%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROIC 19.49%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
GILD Yearly ROA, ROE, ROICGILD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • The Profit Margin of GILD (28.90%) is better than 94.37% of its industry peers.
  • GILD's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 39.98%, GILD belongs to the top of the industry, outperforming 97.67% of the companies in the same industry.
  • GILD's Operating Margin has been stable in the last couple of years.
  • GILD's Gross Margin of 78.83% is amongst the best of the industry. GILD outperforms 83.69% of its industry peers.
  • In the last couple of years the Gross Margin of GILD has remained more or less at the same level.
Industry RankSector Rank
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
GILD Yearly Profit, Operating, Gross MarginsGILD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

6

2. GILD Health Analysis

2.1 Basic Checks

  • GILD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, GILD has less shares outstanding
  • The number of shares outstanding for GILD has been reduced compared to 5 years ago.
  • GILD has a better debt/assets ratio than last year.
GILD Yearly Shares OutstandingGILD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
GILD Yearly Total Debt VS Total AssetsGILD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • GILD has an Altman-Z score of 4.23. This indicates that GILD is financially healthy and has little risk of bankruptcy at the moment.
  • GILD has a Altman-Z score of 4.23. This is in the better half of the industry: GILD outperforms 72.43% of its industry peers.
  • The Debt to FCF ratio of GILD is 2.64, which is a good value as it means it would take GILD, 2.64 years of fcf income to pay off all of its debts.
  • GILD has a better Debt to FCF ratio (2.64) than 93.01% of its industry peers.
  • GILD has a Debt/Equity ratio of 0.97. This is a neutral value indicating GILD is somewhat dependend on debt financing.
  • The Debt to Equity ratio of GILD (0.97) is worse than 75.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Altman-Z 4.23
ROIC/WACC2.14
WACC9.09%
GILD Yearly LT Debt VS Equity VS FCFGILD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • GILD has a Current Ratio of 1.55. This is a normal value and indicates that GILD is financially healthy and should not expect problems in meeting its short term obligations.
  • GILD has a worse Current ratio (1.55) than 82.72% of its industry peers.
  • A Quick Ratio of 1.40 indicates that GILD should not have too much problems paying its short term obligations.
  • GILD has a Quick ratio of 1.40. This is amonst the worse of the industry: GILD underperforms 83.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.4
GILD Yearly Current Assets VS Current LiabilitesGILD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

5

3. GILD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.79% over the past year.
  • Measured over the past 5 years, GILD shows a small growth in Earnings Per Share. The EPS has been growing by 2.83% on average per year.
  • The Revenue has been growing slightly by 2.40% in the past year.
  • Measured over the past years, GILD shows a small growth in Revenue. The Revenue has been growing by 3.58% on average per year.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%

3.2 Future

  • GILD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.02% yearly.
  • GILD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.47% yearly.
EPS Next Y8.48%
EPS Next 2Y9.83%
EPS Next 3Y9.44%
EPS Next 5Y10.02%
Revenue Next Year3.45%
Revenue Next 2Y4.74%
Revenue Next 3Y4.91%
Revenue Next 5Y5.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GILD Yearly Revenue VS EstimatesGILD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
GILD Yearly EPS VS EstimatesGILD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

6

4. GILD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 15.67, which indicates a correct valuation of GILD.
  • Based on the Price/Earnings ratio, GILD is valued cheaply inside the industry as 95.15% of the companies are valued more expensively.
  • GILD is valuated rather cheaply when we compare the Price/Earnings ratio to 27.35, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 14.45, GILD is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GILD indicates a rather cheap valuation: GILD is cheaper than 96.70% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.23. GILD is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.67
Fwd PE 14.45
GILD Price Earnings VS Forward Price EarningsGILD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GILD is valued cheaper than 95.34% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, GILD is valued cheaper than 96.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.77
EV/EBITDA 11.89
GILD Per share dataGILD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • GILD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.85
PEG (5Y)5.55
EPS Next 2Y9.83%
EPS Next 3Y9.44%

7

5. GILD Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.45%, GILD has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.72, GILD pays a better dividend. On top of this GILD pays more dividend than 98.64% of the companies listed in the same industry.
  • GILD's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.45%

5.2 History

  • The dividend of GILD has a limited annual growth rate of 3.30%.
  • GILD has been paying a dividend for at least 10 years, so it has a reliable track record.
  • GILD has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.3%
Div Incr Years10
Div Non Decr Years10
GILD Yearly Dividends per shareGILD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • GILD pays out 47.04% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP47.04%
EPS Next 2Y9.83%
EPS Next 3Y9.44%
GILD Yearly Income VS Free CF VS DividendGILD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
GILD Dividend Payout.GILD Dividend Payout, showing the Payout Ratio.GILD Dividend Payout.PayoutRetained Earnings

GILD Fundamentals: All Metrics, Ratios and Statistics

GILEAD SCIENCES INC

NASDAQ:GILD (4/27/2026, 8:00:01 PM)

After market: 127.852 +0.1 (+0.08%)

127.75

-2.65 (-2.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)05-07
Inst Owners92.8%
Inst Owner Change-0.07%
Ins Owners0.1%
Ins Owner Change1.55%
Market Cap158.57B
Revenue(TTM)29.44B
Net Income(TTM)8.51B
Analysts81.54
Price Target161.35 (26.3%)
Short Float %1.74%
Short Ratio3.18
Dividend
Industry RankSector Rank
Dividend Yield 2.45%
Yearly Dividend3.22
Dividend Growth(5Y)3.3%
DP47.04%
Div Incr Years10
Div Non Decr Years10
Ex-Date03-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.2%
Min EPS beat(2)0.73%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)3.61%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)8
Avg EPS beat(12)7.27%
EPS beat(16)12
Avg EPS beat(16)9.04%
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)0.98%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)2.29%
Revenue beat(8)6
Avg Revenue beat(8)1.67%
Revenue beat(12)8
Avg Revenue beat(12)0.99%
Revenue beat(16)12
Avg Revenue beat(16)2.6%
PT rev (1m)1.47%
PT rev (3m)17.65%
EPS NQ rev (1m)0.29%
EPS NQ rev (3m)-7.86%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-1.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.23%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 15.67
Fwd PE 14.45
P/S 5.39
P/FCF 16.77
P/OCF 15.83
P/B 6.98
P/tB N/A
EV/EBITDA 11.89
EPS(TTM)8.15
EY6.38%
EPS(NY)8.84
Fwd EY6.92%
FCF(TTM)7.62
FCFY5.96%
OCF(TTM)8.07
OCFY6.32%
SpS23.72
BVpS18.29
TBVpS-2.09
PEG (NY)1.85
PEG (5Y)5.55
Graham Number57.9132 (-54.67%)
Profitability
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROCE 24.94%
ROIC 19.49%
ROICexc 25.18%
ROICexgc 81.81%
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
FCFM 32.11%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
ROICexc(3y)21.91%
ROICexc(5y)20.22%
ROICexgc(3y)88.7%
ROICexgc(5y)94.18%
ROCE(3y)22.46%
ROCE(5y)21.44%
ROICexgc growth 3Y-8.45%
ROICexgc growth 5Y-2.47%
ROICexc growth 3Y8.85%
ROICexc growth 5Y10%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Debt/EBITDA 1.52
Cap/Depr 20.4%
Cap/Sales 1.91%
Interest Coverage 11.36
Cash Conversion 68.94%
Profit Quality 111.11%
Current Ratio 1.55
Quick Ratio 1.4
Altman-Z 4.23
F-Score8
WACC9.09%
ROIC/WACC2.14
Cap/Depr(3y)20.34%
Cap/Depr(5y)24.78%
Cap/Sales(3y)1.96%
Cap/Sales(5y)2.14%
Profit Quality(3y)796.33%
Profit Quality(5y)548.85%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y8.48%
EPS Next 2Y9.83%
EPS Next 3Y9.44%
EPS Next 5Y10.02%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.74%
Revenue Next 3Y4.91%
Revenue Next 5Y5.47%
EBIT growth 1Y8.73%
EBIT growth 3Y1.14%
EBIT growth 5Y3.47%
EBIT Next Year26.16%
EBIT Next 3Y11.46%
EBIT Next 5Y10.72%
FCF growth 1Y-8.25%
FCF growth 3Y4.25%
FCF growth 5Y4.69%
OCF growth 1Y-7.48%
OCF growth 3Y3.36%
OCF growth 5Y4.17%

GILEAD SCIENCES INC / GILD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (GILD) stock?

ChartMill assigns a fundamental rating of 6 / 10 to GILD.


What is the valuation status for GILD stock?

ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GILD). This can be considered as Fairly Valued.


What is the profitability of GILD stock?

GILEAD SCIENCES INC (GILD) has a profitability rating of 8 / 10.


What is the expected EPS growth for GILEAD SCIENCES INC (GILD) stock?

The Earnings per Share (EPS) of GILEAD SCIENCES INC (GILD) is expected to grow by 8.48% in the next year.


Is the dividend of GILEAD SCIENCES INC sustainable?

The dividend rating of GILEAD SCIENCES INC (GILD) is 7 / 10 and the dividend payout ratio is 47.04%.